PREDNISONE

PREDNISONE was reported 332454 times

PREDNISONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 255 0.8763
1 SWOLLEN JOINT COUNT INCREASED 442 0.8650
2 PEMPHIGUS 4466 0.8320
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2105 0.8149
4 RHEUMATIC FEVER 493 0.7358
5 GRANULOMA SKIN 345 0.6053
6 RHEUMATOID FACTOR POSITIVE 1473 0.5734
7 HAND DEFORMITY 3575 0.5725
8 DUODENAL ULCER PERFORATION 1272 0.5378
9 BLOOD PRESSURE SYSTOLIC ABNORMAL 622 0.5325
10 BLOOD PRESSURE DIASTOLIC ABNORMAL 767 0.5286
11 BODY HEIGHT BELOW NORMAL 270 0.4515
12 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 748 0.4272
13 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 414 0.4195
14 SECONDARY IMMUNODEFICIENCY 283 0.4049
15 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2366 0.3979
16 SYNOVITIS 4177 0.3915
17 C-REACTIVE PROTEIN ABNORMAL 1131 0.3808
18 BLOOD PARATHYROID HORMONE DECREASED 435 0.3756
19 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 955 0.3665
20 HISTOPLASMOSIS DISSEMINATED 301 0.3529
21 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 467 0.3441
22 HELICOBACTER INFECTION 1427 0.3373
23 CONTRAINDICATED PRODUCT ADMINISTERED 6027 0.3322
24 RHEUMATOID NODULE 682 0.3274
25 FOLLICULITIS 1251 0.3258
26 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 980 0.3253
27 PANNICULITIS 522 0.3197
28 FULL BLOOD COUNT ABNORMAL 713 0.3176
29 MUSCLE INJURY 1164 0.3143
30 STRONGYLOIDIASIS 344 0.3080
31 NOCARDIOSIS 521 0.3076
32 DRUG SPECIFIC ANTIBODY 268 0.3045
33 PERICARDITIS 2528 0.2986
34 FAECAL CALPROTECTIN INCREASED 409 0.2968
35 FORCED EXPIRATORY VOLUME DECREASED 598 0.2963
36 CRYPTOCOCCOSIS 295 0.2950
37 SYSTEMIC LUPUS ERYTHEMATOSUS 5720 0.2941
38 OBSTRUCTIVE AIRWAYS DISORDER 2356 0.2896
39 DRUG TOLERANCE DECREASED 407 0.2840
40 GLOSSODYNIA 4001 0.2816
41 NASAL POLYPS 473 0.2677
42 CUSHINGOID 588 0.2612
43 ASPERGILLUS INFECTION 952 0.2396
44 CYTOMEGALOVIRUS VIRAEMIA 607 0.2381
45 COMPLICATIONS OF TRANSPLANTED KIDNEY 394 0.2299
46 BRONCHIECTASIS 969 0.2298
47 BLOOD IMMUNOGLOBULIN E INCREASED 368 0.2287
48 JUVENILE IDIOPATHIC ARTHRITIS 359 0.2251
49 THERAPEUTIC REACTION TIME DECREASED 254 0.2234
50 KIDNEY TRANSPLANT REJECTION 856 0.2214
51 VARICELLA ZOSTER VIRUS INFECTION 284 0.2214
52 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5784 0.2195
53 SPUTUM DISCOLOURED 1443 0.2183
54 TENOSYNOVITIS 441 0.2156
55 RHEUMATOID ARTHRITIS 16719 0.2156
56 LIMB DEFORMITY 265 0.2110
57 WOUND 3576 0.2109
58 HISTOPLASMOSIS 286 0.2106
59 MYCOBACTERIAL INFECTION 267 0.2054
60 MUCORMYCOSIS 347 0.2029
61 RESPIRATORY SYMPTOM 260 0.2028
62 CYTOMEGALOVIRUS COLITIS 264 0.1992
63 BLOOD PRESSURE DIASTOLIC INCREASED 542 0.1992
64 TRANSPLANT REJECTION 1113 0.1986
65 BK VIRUS INFECTION 394 0.1980
66 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1509 0.1976
67 DRUG LEVEL BELOW THERAPEUTIC 658 0.1931
68 POLYARTHRITIS 635 0.1903
69 HEPATITIS B REACTIVATION 391 0.1865
70 MYCOBACTERIUM AVIUM COMPLEX INFECTION 292 0.1838
71 THERAPEUTIC PRODUCT EFFECT DECREASED 4194 0.1816
72 BONE EROSION 387 0.1810
73 BLOOD PRESSURE DIASTOLIC DECREASED 922 0.1797
74 SENSITIVITY TO WEATHER CHANGE 571 0.1793
75 CHRONIC SINUSITIS 436 0.1780
76 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6309 0.1749
77 HYPERPARATHYROIDISM SECONDARY 369 0.1739
78 DIFFUSE LARGE B-CELL LYMPHOMA 696 0.1700
79 WHEEZING 6627 0.1695
80 ARTHROPATHY 6351 0.1668
81 EPSTEIN-BARR VIRUS INFECTION 716 0.1660
82 BLOOD PRESSURE SYSTOLIC INCREASED 2116 0.1660
83 BRAIN ABSCESS 276 0.1656
84 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 344 0.1644
85 BREATH SOUNDS ABNORMAL 544 0.1640
86 ASTHMA 11070 0.1626
87 BLOOD PRESSURE FLUCTUATION 2891 0.1625
88 PNEUMOCYSTIS JIROVECII PNEUMONIA 990 0.1614
89 COLITIS ULCERATIVE 3683 0.1591
90 POLYMYALGIA RHEUMATICA 303 0.1566
91 NEPHROGENIC ANAEMIA 647 0.1557
92 BLOOD COUNT ABNORMAL 2585 0.1552
93 ADRENAL INSUFFICIENCY 1032 0.1551
94 INFUSION RELATED REACTION 6442 0.1547
95 BRONCHOPULMONARY ASPERGILLOSIS 788 0.1529
96 ADENOVIRUS INFECTION 272 0.1508
97 CYTOMEGALOVIRUS INFECTION 1686 0.1439
98 JOINT SWELLING 11301 0.1428
99 RHINITIS ALLERGIC 410 0.1384
100 JOINT EFFUSION 727 0.1373
101 MUCOUS STOOLS 364 0.1361
102 THERAPY PARTIAL RESPONDER 569 0.1357
103 EOSINOPHIL COUNT INCREASED 790 0.1351
104 RED CELL DISTRIBUTION WIDTH INCREASED 346 0.1327
105 OESOPHAGEAL CANDIDIASIS 356 0.1297
106 DRUG INTOLERANCE 8022 0.1291
107 BODY TEMPERATURE DECREASED 951 0.1289
108 SKIN NECROSIS 532 0.1286
109 OBSTRUCTION 310 0.1286
110 SARCOIDOSIS 451 0.1285
111 PRODUCTIVE COUGH 3995 0.1283
112 LUNG CONSOLIDATION 268 0.1279
113 IRRITABLE BOWEL SYNDROME 1669 0.1268
114 KLEBSIELLA INFECTION 424 0.1258
115 FOOT DEFORMITY 1003 0.1255
116 PULMONARY FUNCTION TEST DECREASED 420 0.1236
117 HIP ARTHROPLASTY 1114 0.1223
118 HYPOGAMMAGLOBULINAEMIA 405 0.1217
119 SYNOVIAL CYST 420 0.1207
120 LOWER RESPIRATORY TRACT INFECTION 3567 0.1200
121 ENTEROCOCCAL INFECTION 404 0.1193
122 PSEUDOMONAS INFECTION 683 0.1187
123 POOR VENOUS ACCESS 671 0.1185
124 PULMONARY MASS 1180 0.1179
125 ARTHRITIS BACTERIAL 354 0.1176
126 JOINT RANGE OF MOTION DECREASED 910 0.1174
127 KNEE ARTHROPLASTY 1425 0.1172
128 SWELLING 7390 0.1167
129 HAEMATOTOXICITY 641 0.1165
130 RALES 501 0.1150
131 PLEURITIC PAIN 254 0.1144
132 FINGER DEFORMITY 369 0.1144
133 TREATMENT FAILURE 6058 0.1140
134 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 293 0.1135
135 GRANULOMA 290 0.1132
136 B-CELL LYMPHOMA 303 0.1125
137 PROSTATE CANCER METASTATIC 269 0.1112
138 GRIP STRENGTH DECREASED 516 0.1110
139 DRUG LEVEL ABOVE THERAPEUTIC 286 0.1109
140 IMPAIRED HEALING 2565 0.1106
141 C-REACTIVE PROTEIN INCREASED 2722 0.1105
142 CLOSTRIDIUM DIFFICILE INFECTION 1596 0.1097
143 VASCULITIS 875 0.1097
144 RESPIRATORY RATE INCREASED 701 0.1094
145 CANDIDA INFECTION 1148 0.1089
146 DRUG LEVEL DECREASED 643 0.1068
147 CREPITATIONS 261 0.1065
148 ANAL FISSURE 304 0.1058
149 PULMONARY FIBROSIS 1321 0.1054
150 REBOUND ACID HYPERSECRETION 304 0.1051
151 ATELECTASIS 817 0.1050
152 PULMONARY TOXICITY 415 0.1050
153 INTENTIONAL PRODUCT USE ISSUE 5275 0.1040
154 WHEELCHAIR USER 328 0.1035
155 UPPER-AIRWAY COUGH SYNDROME 556 0.1032
156 IMMUNODEFICIENCY 877 0.1028
157 GRAFT VERSUS HOST DISEASE 578 0.1024
158 CHRONIC GRAFT VERSUS HOST DISEASE 254 0.1023
159 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 639 0.1020
160 INFLAMMATION 3206 0.1018
161 BURSITIS 738 0.1008
162 OSTEOPOROSIS 3163 0.1008
163 CHEST X-RAY ABNORMAL 265 0.1007
164 IMMUNOSUPPRESSION 538 0.1004
165 DEFAECATION URGENCY 371 0.0998
166 STAPHYLOCOCCAL BACTERAEMIA 290 0.0997
167 SINUSITIS 7087 0.0995
168 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 634 0.0995
169 MUSCULOSKELETAL STIFFNESS 6025 0.0994
170 BASAL CELL CARCINOMA 1101 0.0990
171 NODULE 886 0.0986
172 EMPHYSEMA 780 0.0985
173 DISCOMFORT 3647 0.0977
174 ESCHERICHIA INFECTION 543 0.0975
175 FIBROMYALGIA 1567 0.0972
176 APHTHOUS ULCER 379 0.0970
177 HEPATIC ENZYME INCREASED 4344 0.0970
178 FREQUENT BOWEL MOVEMENTS 1565 0.0969
179 FUNGAL SKIN INFECTION 269 0.0967
180 ESCHERICHIA URINARY TRACT INFECTION 310 0.0965
181 ANAL ABSCESS 319 0.0962
182 OSTEOARTHRITIS 2849 0.0961
183 ABSCESS LIMB 281 0.0960
184 NEPHROGENIC SYSTEMIC FIBROSIS 286 0.0957
185 BLOOD TEST ABNORMAL 832 0.0952
186 CLOSTRIDIUM DIFFICILE COLITIS 729 0.0951
187 ORAL CANDIDIASIS 844 0.0949
188 ARTHRITIS INFECTIVE 312 0.0947
189 SKIN ATROPHY 386 0.0946
190 DRUG SPECIFIC ANTIBODY PRESENT 348 0.0945
191 PSORIATIC ARTHROPATHY 2015 0.0945
192 SQUAMOUS CELL CARCINOMA OF SKIN 388 0.0944
193 SEPTIC SHOCK 2858 0.0943
194 END STAGE RENAL DISEASE 1454 0.0941
195 DISEASE RECURRENCE 1592 0.0940
196 INTERVERTEBRAL DISC DEGENERATION 714 0.0937
197 TUMOUR LYSIS SYNDROME 533 0.0933
198 OSTEOPENIA 1057 0.0920
199 THERAPEUTIC RESPONSE SHORTENED 847 0.0918
200 SKIN ULCER 1770 0.0915
201 PERIPHERAL SWELLING 8984 0.0912
202 ARTHRITIS 4922 0.0908
203 MYOPATHY 593 0.0906
204 RHINITIS 522 0.0903
205 ABDOMINAL ABSCESS 289 0.0903
206 HISTIOCYTOSIS HAEMATOPHAGIC 271 0.0896
207 COVID-19 PNEUMONIA 515 0.0893
208 RESPIRATORY TRACT CONGESTION 975 0.0893
209 DYSPNOEA EXERTIONAL 2273 0.0890
210 FEBRILE NEUTROPENIA 3973 0.0890
211 BODY TEMPERATURE INCREASED 1380 0.0888
212 UVEITIS 678 0.0887
213 OXYGEN SATURATION DECREASED 3219 0.0887
214 SECOND PRIMARY MALIGNANCY 537 0.0886
215 HYPERCALCAEMIA 804 0.0882
216 SPINAL OSTEOARTHRITIS 591 0.0874
217 BACTERAEMIA 675 0.0874
218 IMMOBILE 280 0.0870
219 LUNG INFECTION 1360 0.0869
220 SCIATICA 847 0.0866
221 LUNG INFILTRATION 664 0.0866
222 SECRETION DISCHARGE 670 0.0865
223 POLYP 410 0.0864
224 CROHN'S DISEASE 592 0.0863
225 HERPES ZOSTER 3553 0.0863
226 EAR PAIN 1208 0.0858
227 RENAL TUBULAR NECROSIS 614 0.0854
228 ENTERITIS 347 0.0850
229 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3305 0.0849
230 WALKING AID USER 379 0.0846
231 BACTERIAL INFECTION 1063 0.0846
232 TOOTH INFECTION 763 0.0845
233 HERPES SIMPLEX 400 0.0844
234 JOINT STIFFNESS 1600 0.0841
235 EXOSTOSIS 542 0.0841
236 SEASONAL ALLERGY 662 0.0840
237 INFECTION 7915 0.0837
238 CYTOPENIA 451 0.0834
239 MACULAR DEGENERATION 698 0.0831
240 DIARRHOEA HAEMORRHAGIC 574 0.0830
241 ORGANISING PNEUMONIA 254 0.0830
242 RESPIRATORY DISORDER 1843 0.0829
243 MYASTHENIA GRAVIS 290 0.0827
244 ENCEPHALITIS 386 0.0825
245 WOUND INFECTION 534 0.0823
246 SLEEP APNOEA SYNDROME 1249 0.0821
247 CONDITION AGGRAVATED 14845 0.0821
248 MYELODYSPLASTIC SYNDROME 894 0.0818
249 HEART RATE DECREASED 2101 0.0814
250 ILL-DEFINED DISORDER 2425 0.0813
251 FEAR OF INJECTION 300 0.0808
252 LUPUS-LIKE SYNDROME 484 0.0807
253 MULTIPLE ALLERGIES 399 0.0807
254 POSTOPERATIVE WOUND INFECTION 376 0.0807
255 HEPATITIS B 383 0.0804
256 COMPRESSION FRACTURE 266 0.0802
257 SMALL INTESTINAL OBSTRUCTION 703 0.0797
258 WHITE BLOOD CELL COUNT ABNORMAL 345 0.0797
259 GASTROINTESTINAL INFLAMMATION 418 0.0796
260 LIVE BIRTH 363 0.0795
261 SKIN LACERATION 482 0.0787
262 ANKYLOSING SPONDYLITIS 517 0.0784
263 SINUS CONGESTION 760 0.0783
264 LYMPHOPENIA 741 0.0783
265 ULCER 905 0.0779
266 SKIN INFECTION 571 0.0779
267 POST PROCEDURAL INFECTION 419 0.0778
268 ACUTE MYELOID LEUKAEMIA 849 0.0777
269 ARTHRALGIA 20945 0.0772
270 BRONCHITIS 4363 0.0771
271 AUTOIMMUNE DISORDER 355 0.0771
272 CARPAL TUNNEL SYNDROME 776 0.0769
273 INCREASED TENDENCY TO BRUISE 548 0.0769
274 COLITIS 1871 0.0767
275 ROTATOR CUFF SYNDROME 751 0.0765
276 DYSLIPIDAEMIA 277 0.0764
277 OBESITY 828 0.0759
278 UPPER RESPIRATORY TRACT INFECTION 2447 0.0758
279 CYST 670 0.0757
280 WEIGHT FLUCTUATION 487 0.0754
281 MATERNAL EXPOSURE DURING PREGNANCY 3934 0.0754
282 SPINAL COMPRESSION FRACTURE 501 0.0752
283 MOBILITY DECREASED 3678 0.0751
284 SQUAMOUS CELL CARCINOMA 531 0.0751
285 LOCALISED INFECTION 1276 0.0750
286 ACUTE RESPIRATORY FAILURE 976 0.0750
287 COLECTOMY 275 0.0748
288 PERIPHERAL SENSORY NEUROPATHY 305 0.0745
289 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1159 0.0744
290 RESPIRATORY TRACT INFECTION 1287 0.0742
291 HAEMATOCHEZIA 2715 0.0742
292 PROCTALGIA 339 0.0741
293 CATARACT 2918 0.0740
294 TENDON DISORDER 366 0.0738
295 HYPERCHOLESTEROLAEMIA 442 0.0737
296 PROSTATIC SPECIFIC ANTIGEN INCREASED 726 0.0737
297 INTERSTITIAL LUNG DISEASE 2467 0.0734
298 FISTULA 552 0.0732
299 MOUTH ULCERATION 1046 0.0726
300 TENDERNESS 563 0.0725
301 NEUTROPHIL COUNT INCREASED 553 0.0722
302 TOOTH ABSCESS 576 0.0722
303 ABSCESS 794 0.0722
304 ABDOMINAL DISCOMFORT 8156 0.0722
305 JOINT INJURY 1073 0.0720
306 PNEUMONITIS 1274 0.0719
307 BLOOD IRON DECREASED 517 0.0718
308 SKIN LESION 1368 0.0717
309 NEPHROPATHY TOXIC 526 0.0715
310 BONE DISORDER 1086 0.0715
311 NIGHT SWEATS 1589 0.0712
312 BLISTER 2700 0.0711
313 RIB FRACTURE 1076 0.0709
314 PULMONARY CONGESTION 692 0.0709
315 MASS 743 0.0704
316 NASAL CONGESTION 2661 0.0700
317 NASOPHARYNGITIS 8502 0.0699
318 LUNG DISORDER 2411 0.0699
319 ENDOCARDITIS 262 0.0697
320 ANAL FISTULA 252 0.0697
321 FOOD ALLERGY 282 0.0695
322 DEFORMITY 503 0.0695
323 ACUTE RESPIRATORY DISTRESS SYNDROME 918 0.0694
324 VIRAL UPPER RESPIRATORY TRACT INFECTION 285 0.0692
325 GOUT 905 0.0691
326 HERPES VIRUS INFECTION 290 0.0689
327 CELLULITIS 2611 0.0689
328 VIRAL INFECTION 1566 0.0687
329 GASTROINTESTINAL DISORDER 3525 0.0685
330 ECCHYMOSIS 375 0.0683
331 PANCYTOPENIA 2667 0.0679
332 OSTEOMYELITIS 984 0.0676
333 IMPAIRED QUALITY OF LIFE 475 0.0676
334 PNEUMONIA 15158 0.0675
335 ORAL HERPES 832 0.0672
336 COUGH 12450 0.0672
337 LYMPHADENOPATHY 1744 0.0672
338 THERAPY NON-RESPONDER 1549 0.0672
339 TENDON RUPTURE 657 0.0671
340 MUSCULOSKELETAL PAIN 3073 0.0670
341 KIDNEY INFECTION 914 0.0669
342 HYPOXIA 1647 0.0669
343 IMMUNE SYSTEM DISORDER 616 0.0667
344 RESPIRATORY FAILURE 3668 0.0664
345 HEART RATE IRREGULAR 1218 0.0664
346 TUBERCULOSIS 616 0.0662
347 BENIGN PROSTATIC HYPERPLASIA 271 0.0662
348 STOMATITIS 2793 0.0661
349 PNEUMONIA BACTERIAL 359 0.0661
350 PLEURISY 324 0.0661
351 DIVERTICULITIS 1321 0.0660
352 SKIN PLAQUE 354 0.0659
353 HIATUS HERNIA 689 0.0659
354 STAPHYLOCOCCAL INFECTION 1730 0.0658
355 FLANK PAIN 450 0.0658
356 COVID-19 2627 0.0657
357 PHARYNGEAL SWELLING 256 0.0651
358 BLOOD ALBUMIN DECREASED 392 0.0651
359 PYELONEPHRITIS 406 0.0650
360 LIVER FUNCTION TEST INCREASED 830 0.0649
361 FUNGAL INFECTION 1555 0.0648
362 INFUSION SITE EXTRAVASATION 283 0.0648
363 UROSEPSIS 420 0.0644
364 GASTROINTESTINAL INFECTION 395 0.0643
365 WEIGHT INCREASED 10095 0.0642
366 FOOT FRACTURE 923 0.0640
367 IRON DEFICIENCY ANAEMIA 431 0.0639
368 JOINT DISLOCATION 481 0.0638
369 MUCOSAL INFLAMMATION 1208 0.0638
370 THROMBOTIC MICROANGIOPATHY 393 0.0637
371 SPINAL DISORDER 451 0.0635
372 GAIT INABILITY 1055 0.0634
373 NEPHROTIC SYNDROME 309 0.0631
374 GASTROENTERITIS 675 0.0631
375 CHRONIC KIDNEY DISEASE 4114 0.0628
376 HYDRONEPHROSIS 347 0.0627
377 SKIN MASS 271 0.0627
378 GASTROENTERITIS VIRAL 752 0.0627
379 INTESTINAL PERFORATION 521 0.0626
380 CONTUSION 4257 0.0626
381 INFLUENZA 4471 0.0625
382 RENAL CYST 385 0.0625
383 TUBULOINTERSTITIAL NEPHRITIS 829 0.0625
384 SEPSIS 5089 0.0624
385 HAEMOLYSIS 369 0.0622
386 PHARYNGITIS 577 0.0617
387 HEPATOTOXICITY 934 0.0616
388 OROPHARYNGEAL PAIN 3863 0.0614
389 CYSTITIS 1511 0.0613
390 GLAUCOMA 866 0.0612
391 ODYNOPHAGIA 256 0.0612
392 NERVE COMPRESSION 399 0.0612
393 SPINAL COLUMN STENOSIS 290 0.0611
394 TENDONITIS 736 0.0608
395 GASTROOESOPHAGEAL REFLUX DISEASE 3485 0.0608
396 PROTEINURIA 748 0.0607
397 EYE INFECTION 433 0.0606
398 FURUNCLE 362 0.0605
399 RESPIRATION ABNORMAL 253 0.0603
400 FRUSTRATION TOLERANCE DECREASED 290 0.0603
401 EAR INFECTION 1030 0.0601
402 LEUKOPENIA 2187 0.0598
403 DIVERTICULUM 378 0.0598
404 MALNUTRITION 458 0.0597
405 MUSCULOSKELETAL CHEST PAIN 664 0.0596
406 MUSCULOSKELETAL DISORDER 863 0.0595
407 BLOOD PRESSURE INCREASED 6487 0.0594
408 TRICUSPID VALVE INCOMPETENCE 344 0.0593
409 CARDIOTOXICITY 300 0.0591
410 SINUS DISORDER 812 0.0588
411 LARYNGITIS 440 0.0588
412 HAEMATOCRIT DECREASED 954 0.0585
413 MYOSITIS 348 0.0584
414 SPLENOMEGALY 508 0.0583
415 PNEUMOTHORAX 647 0.0583
416 RHINORRHOEA 2515 0.0583
417 SPINAL FRACTURE 793 0.0582
418 PLATELET COUNT INCREASED 525 0.0582
419 NEPHROLITHIASIS 1841 0.0581
420 LARGE INTESTINE PERFORATION 306 0.0581
421 PELVIC FRACTURE 322 0.0579
422 BLOOD CHOLESTEROL INCREASED 1911 0.0578
423 EOSINOPHILIA 695 0.0577
424 CHEST DISCOMFORT 4109 0.0577
425 LYMPHOMA 640 0.0575
426 STRESS FRACTURE 255 0.0574
427 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 263 0.0574
428 NEUTROPENIC SEPSIS 319 0.0571
429 VITAMIN D DEFICIENCY 394 0.0569
430 HEART RATE INCREASED 4026 0.0569
431 LIGAMENT SPRAIN 383 0.0567
432 DIABETES MELLITUS 3335 0.0566
433 BEDRIDDEN 543 0.0566
434 INTERVERTEBRAL DISC PROTRUSION 971 0.0566
435 ALOPECIA 8236 0.0565
436 LEUKOCYTOSIS 758 0.0564
437 SPINAL PAIN 438 0.0562
438 LIMB INJURY 1021 0.0561
439 PHARYNGITIS STREPTOCOCCAL 397 0.0560
440 OFF LABEL USE 25262 0.0560
441 RECTAL HAEMORRHAGE 1835 0.0559
442 NERVE INJURY 471 0.0558
443 TOOTH FRACTURE 459 0.0557
444 HYPERSENSITIVITY 7368 0.0556
445 PYREXIA 13845 0.0556
446 WHITE BLOOD CELL COUNT INCREASED 1652 0.0551
447 MYELOSUPPRESSION 291 0.0548
448 PULMONARY HAEMORRHAGE 340 0.0548
449 NECK PAIN 2194 0.0548
450 DRUG ERUPTION 655 0.0547
451 AUTOIMMUNE HEPATITIS 261 0.0546
452 URINARY TRACT INFECTION 6325 0.0545
453 DYSPNOEA 22723 0.0544
454 TYPE 2 DIABETES MELLITUS 1369 0.0541
455 SCOLIOSIS 254 0.0541
456 MUSCULOSKELETAL DISCOMFORT 650 0.0540
457 ANKLE FRACTURE 615 0.0539
458 MITRAL VALVE INCOMPETENCE 478 0.0539
459 PRODUCT USE IN UNAPPROVED INDICATION 7173 0.0538
460 LEFT VENTRICULAR DYSFUNCTION 262 0.0538
461 WEIGHT DECREASED 10604 0.0538
462 PAIN 24421 0.0536
463 ACUTE KIDNEY INJURY 5374 0.0535
464 MUSCLE SPASTICITY 540 0.0534
465 HYPERGLYCAEMIA 1492 0.0533
466 CARDIOMYOPATHY 616 0.0532
467 MALIGNANT MELANOMA 538 0.0532
468 ARTHROPOD BITE 278 0.0528
469 PRODUCT USE ISSUE 6432 0.0528
470 BLOOD MAGNESIUM DECREASED 307 0.0528
471 MENINGITIS 259 0.0527
472 MUSCLE STRAIN 337 0.0525
473 HERNIA 681 0.0525
474 PLEURAL EFFUSION 2393 0.0522
475 APHONIA 483 0.0521
476 HYPERTENSION 7809 0.0521
477 DECREASED ACTIVITY 364 0.0521
478 HAEMOGLOBIN DECREASED 3984 0.0521
479 TONGUE DISORDER 313 0.0520
480 INTESTINAL OBSTRUCTION 1326 0.0517
481 DISABILITY 701 0.0516
482 THERAPEUTIC RESPONSE DECREASED 2188 0.0515
483 NEUROTOXICITY 561 0.0514
484 LIVER INJURY 635 0.0513
485 NEUTROPENIA 4250 0.0513
486 PAIN IN EXTREMITY 11274 0.0513
487 THYROID DISORDER 545 0.0511
488 RESPIRATORY DISTRESS 1094 0.0510
489 HAEMORRHOIDS 760 0.0509
490 VITAMIN D DECREASED 321 0.0506
491 EYE INFLAMMATION 276 0.0505
492 ORAL DISORDER 278 0.0504
493 DRUG RESISTANCE 851 0.0503
494 SCRATCH 292 0.0503
495 HEPATIC STEATOSIS 685 0.0500
496 WRIST FRACTURE 437 0.0500
497 LYMPHOCYTE COUNT DECREASED 618 0.0495
498 HAEMOPTYSIS 1073 0.0495
499 TOOTH DISORDER 836 0.0494
500 NEURALGIA 834 0.0494
501 ABDOMINAL PAIN 8224 0.0494
502 REBOUND EFFECT 270 0.0494
503 BONE MARROW FAILURE 888 0.0492
504 OEDEMA 1891 0.0492
505 CARDIAC MURMUR 354 0.0490
506 PULMONARY THROMBOSIS 374 0.0487
507 DENTAL CARIES 411 0.0487
508 LOCAL SWELLING 850 0.0486
509 HYPERLIPIDAEMIA 482 0.0486
510 CARDIOMEGALY 511 0.0484
511 DRUG HYPERSENSITIVITY 7133 0.0484
512 NAIL DISORDER 261 0.0483
513 IMPAIRED WORK ABILITY 822 0.0482
514 HYPERBILIRUBINAEMIA 352 0.0476
515 BLOOD CREATININE INCREASED 2346 0.0476
516 RASH 13873 0.0476
517 GROIN PAIN 317 0.0475
518 CONJUNCTIVITIS 520 0.0475
519 THROMBOCYTOPENIA 3694 0.0472
520 GENERAL PHYSICAL HEALTH DETERIORATION 3410 0.0471
521 RENAL FAILURE 5135 0.0471
522 BACK PAIN 7921 0.0469
523 POLYNEUROPATHY 370 0.0469
524 MIDDLE INSOMNIA 609 0.0469
525 FACIAL PAIN 295 0.0469
526 RASH PRURITIC 1715 0.0466
527 FATIGUE 25402 0.0466
528 ANAEMIA 6577 0.0465
529 STRESS 2251 0.0464
530 GASTRIC ULCER 697 0.0464
531 GENERALISED OEDEMA 398 0.0463
532 ATRIAL FIBRILLATION 3250 0.0463
533 FACIAL PARALYSIS 257 0.0461
534 BLOOD POTASSIUM DECREASED 1034 0.0460
535 DECUBITUS ULCER 287 0.0460
536 GASTROINTESTINAL PAIN 336 0.0459
537 OEDEMA PERIPHERAL 4525 0.0458
538 BLOOD LACTATE DEHYDROGENASE INCREASED 595 0.0457
539 HYPOTHYROIDISM 983 0.0457
540 ARTERIOSCLEROSIS 334 0.0457
541 PULMONARY HYPERTENSION 753 0.0456
542 NEUROPATHY PERIPHERAL 2816 0.0456
543 PERICARDIAL EFFUSION 748 0.0455
544 RENAL FAILURE CHRONIC 350 0.0455
545 HEPATIC CIRRHOSIS 580 0.0454
546 PATHOGEN RESISTANCE 270 0.0454
547 HAEMOLYTIC ANAEMIA 320 0.0454
548 UPPER LIMB FRACTURE 698 0.0454
549 DEEP VEIN THROMBOSIS 2457 0.0453
550 NEPHROPATHY 342 0.0453
551 DERMATITIS ALLERGIC 374 0.0450
552 DYSPHONIA 1825 0.0449
553 URTICARIA 5144 0.0449
554 DRUG INEFFECTIVE 42143 0.0449
555 TRANSAMINASES INCREASED 768 0.0448
556 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3404 0.0448
557 MYOCARDITIS 290 0.0447
558 DRUG LEVEL INCREASED 526 0.0447
559 LACERATION 421 0.0447
560 BACK INJURY 314 0.0446
561 BODY HEIGHT DECREASED 405 0.0445
562 ECZEMA 859 0.0444
563 OESOPHAGITIS 364 0.0444
564 SLEEP DISORDER 2011 0.0444
565 GAIT DISTURBANCE 6275 0.0444
566 DISEASE PROGRESSION 3217 0.0443
567 PHOTOSENSITIVITY REACTION 531 0.0441
568 LOWER LIMB FRACTURE 545 0.0441
569 POOR QUALITY SLEEP 636 0.0439
570 ATRIAL FLUTTER 274 0.0439
571 LIMB DISCOMFORT 964 0.0438
572 QUALITY OF LIFE DECREASED 437 0.0436
573 ACUTE HEPATIC FAILURE 417 0.0436
574 ILLNESS 1144 0.0435
575 SKIN CANCER 601 0.0432
576 ASTHENIA 11635 0.0431
577 HEPATITIS 816 0.0430
578 RED BLOOD CELL COUNT DECREASED 875 0.0430
579 POST PROCEDURAL COMPLICATION 643 0.0430
580 MUSCULAR WEAKNESS 3571 0.0430
581 MUSCLE ATROPHY 360 0.0426
582 PULMONARY EMBOLISM 3241 0.0426
583 RENAL IMPAIRMENT 2426 0.0425
584 PAIN IN JAW 946 0.0423
585 APPENDICITIS 268 0.0423
586 FEEDING DISORDER 467 0.0422
587 CHILLS 3557 0.0421
588 OSTEONECROSIS 1170 0.0421
589 DRY EYE 1133 0.0421
590 HYPOPHAGIA 753 0.0418
591 SKIN DISORDER 920 0.0417
592 BRONCHOSPASM 460 0.0416
593 DERMATITIS ATOPIC 363 0.0416
594 SCAR 551 0.0415
595 SNEEZING 594 0.0413
596 EAR DISCOMFORT 295 0.0412
597 MENTAL STATUS CHANGES 898 0.0411
598 TOOTHACHE 539 0.0411
599 EJECTION FRACTION DECREASED 463 0.0411
600 ALANINE AMINOTRANSFERASE INCREASED 1935 0.0411
601 PNEUMONIA ASPIRATION 745 0.0410
602 PETECHIAE 318 0.0410
603 GASTRIC DISORDER 1284 0.0410
604 HEPATOMEGALY 324 0.0410
605 THROAT IRRITATION 1272 0.0408
606 GLOMERULAR FILTRATION RATE DECREASED 291 0.0408
607 HYPOKALAEMIA 1322 0.0406
608 PULMONARY OEDEMA 1352 0.0406
609 PURPURA 282 0.0405
610 BLOOD URINE PRESENT 594 0.0403
611 SCAB 324 0.0401
612 MULTI-ORGAN FAILURE 695 0.0401
613 DERMATITIS 545 0.0400
614 SWELLING FACE 1909 0.0399
615 FEMUR FRACTURE 1016 0.0399
616 BLOOD PRESSURE ABNORMAL 517 0.0399
617 SUPRAVENTRICULAR TACHYCARDIA 294 0.0398
618 ORAL PAIN 676 0.0398
619 SINUS TACHYCARDIA 433 0.0398
620 GASTRITIS 798 0.0397
621 EYE DISORDER 925 0.0397
622 DRUG-INDUCED LIVER INJURY 676 0.0397
623 EMBOLISM 258 0.0396
624 THROMBOSIS 2363 0.0395
625 BACK DISORDER 464 0.0394
626 EXPOSURE DURING PREGNANCY 1665 0.0393
627 DIARRHOEA 17506 0.0392
628 NEOPLASM 298 0.0392
629 TACHYPNOEA 361 0.0392
630 DRUG EFFECT INCOMPLETE 1429 0.0392
631 CHEST PAIN 5538 0.0391
632 COAGULOPATHY 516 0.0390
633 HYPOKINESIA 425 0.0388
634 ASPARTATE AMINOTRANSFERASE INCREASED 1583 0.0388
635 DEHYDRATION 3873 0.0387
636 INFLAMMATORY BOWEL DISEASE 301 0.0387
637 PLATELET COUNT DECREASED 2839 0.0385
638 CHOLECYSTECTOMY 315 0.0385
639 ANAPHYLACTIC REACTION 1415 0.0384
640 METASTASES TO BONE 392 0.0383
641 PHOTOPHOBIA 481 0.0382
642 HYPOAESTHESIA 4203 0.0381
643 RENAL INJURY 1020 0.0380
644 DYSSTASIA 836 0.0379
645 CHOLELITHIASIS 949 0.0378
646 MALAISE 12500 0.0378
647 ENCEPHALOPATHY 663 0.0378
648 GINGIVAL BLEEDING 353 0.0376
649 BONE PAIN 1619 0.0374
650 DEVICE RELATED INFECTION 457 0.0374
651 BONE DENSITY DECREASED 985 0.0373
652 FLUID RETENTION 1436 0.0373
653 HIP FRACTURE 870 0.0373
654 BLOOD UREA INCREASED 518 0.0370
655 MIGRAINE 2349 0.0370
656 INJECTION SITE BRUISING 2036 0.0370
657 THROAT TIGHTNESS 744 0.0370
658 GALLBLADDER DISORDER 534 0.0369
659 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 312 0.0369
660 PRURITUS 8555 0.0367
661 URINE OUTPUT DECREASED 254 0.0366
662 INJECTION SITE EXTRAVASATION 391 0.0365
663 ELECTROLYTE IMBALANCE 287 0.0364
664 RASH ERYTHEMATOUS 1096 0.0364
665 ASPIRATION 278 0.0364
666 ABDOMINAL DISTENSION 2664 0.0364
667 OPTIC NEURITIS 254 0.0363
668 SKIN DISCOLOURATION 1245 0.0362
669 FLUID OVERLOAD 530 0.0361
670 TOOTH EXTRACTION 343 0.0360
671 BLOOD CALCIUM DECREASED 305 0.0360
672 PREMATURE DELIVERY 415 0.0360
673 LIVER FUNCTION TEST ABNORMAL 908 0.0359
674 INJECTION SITE RASH 700 0.0359
675 THERAPY INTERRUPTED 495 0.0359
676 HEADACHE 16265 0.0359
677 SKIN HAEMORRHAGE 293 0.0358
678 DECREASED APPETITE 5586 0.0358
679 BLADDER DISORDER 266 0.0356
680 HEAD DISCOMFORT 410 0.0356
681 PREMATURE BABY 807 0.0356
682 HAEMATURIA 960 0.0355
683 INFUSION SITE PAIN 258 0.0355
684 HYPOTENSION 5128 0.0353
685 ABDOMINAL PAIN UPPER 5107 0.0353
686 TRANSFUSION 279 0.0353
687 MICTURITION URGENCY 285 0.0353
688 BLOOD POTASSIUM INCREASED 435 0.0352
689 CORONARY ARTERY OCCLUSION 410 0.0351
690 FRACTURE 487 0.0351
691 BLOOD PRESSURE DECREASED 1690 0.0351
692 ECONOMIC PROBLEM 502 0.0348
693 ILEUS 307 0.0347
694 RENAL PAIN 267 0.0347
695 DERMATITIS CONTACT 273 0.0346
696 DYSPEPSIA 2390 0.0346
697 FALL 8485 0.0345
698 DRY THROAT 255 0.0345
699 INJECTION SITE DISCOLOURATION 307 0.0343
700 HAEMATOMA 716 0.0342
701 LACRIMATION INCREASED 640 0.0340
702 DYSURIA 962 0.0339
703 INCREASED APPETITE 414 0.0339
704 ADVERSE DRUG REACTION 1860 0.0339
705 DYSPHAGIA 2274 0.0338
706 INJECTION SITE IRRITATION 323 0.0337
707 MULTIPLE FRACTURES 452 0.0337
708 PANCREATITIS 1351 0.0336
709 DISSEMINATED INTRAVASCULAR COAGULATION 382 0.0335
710 RENAL DISORDER 1150 0.0334
711 EYE HAEMORRHAGE 340 0.0334
712 INSOMNIA 6695 0.0334
713 HYPERKALAEMIA 844 0.0331
714 VOMITING 11240 0.0330
715 CHOLECYSTITIS 293 0.0328
716 RASH MACULAR 788 0.0328
717 ANHEDONIA 721 0.0328
718 NAUSEA 18442 0.0327
719 PALLOR 621 0.0327
720 POLLAKIURIA 988 0.0326
721 FEELING COLD 680 0.0325
722 EATING DISORDER 502 0.0325
723 ASCITES 717 0.0325
724 TACHYCARDIA 2088 0.0324
725 CONFUSIONAL STATE 3922 0.0324
726 CARDIAC FAILURE CONGESTIVE 2298 0.0324
727 HYPOCALCAEMIA 436 0.0324
728 PERIPHERAL COLDNESS 327 0.0323
729 WHITE BLOOD CELL COUNT DECREASED 2391 0.0322
730 BLOOD SODIUM DECREASED 443 0.0318
731 PHARYNGEAL OEDEMA 477 0.0317
732 FEELING HOT 1386 0.0316
733 PARAESTHESIA ORAL 317 0.0316
734 CARDIOGENIC SHOCK 293 0.0315
735 EYE SWELLING 849 0.0315
736 HYPOMAGNESAEMIA 286 0.0314
737 LABORATORY TEST ABNORMAL 666 0.0313
738 PLASMA CELL MYELOMA 820 0.0313
739 DRUG EFFECT DECREASED 1686 0.0312
740 BLINDNESS UNILATERAL 320 0.0311
741 NEUTROPHIL COUNT DECREASED 819 0.0311
742 BURNING SENSATION 1623 0.0311
743 MOVEMENT DISORDER 755 0.0310
744 OSTEONECROSIS OF JAW 640 0.0310
745 INFLUENZA LIKE ILLNESS 2015 0.0309
746 MYALGIA 3864 0.0308
747 EYE PRURITUS 569 0.0308
748 INJECTION SITE PRURITUS 1488 0.0308
749 BLINDNESS 888 0.0307
750 DIABETES MELLITUS INADEQUATE CONTROL 413 0.0306
751 ANGINA PECTORIS 717 0.0305
752 HEPATIC FAILURE 723 0.0305
753 RASH MACULO-PAPULAR 478 0.0305
754 DRUG INTERACTION 3594 0.0304
755 HYPOAESTHESIA ORAL 339 0.0303
756 SURGERY 1088 0.0302
757 RENAL FAILURE ACUTE 1282 0.0302
758 PARAESTHESIA 3500 0.0301
759 PSORIASIS 2693 0.0301
760 AGRANULOCYTOSIS 359 0.0301
761 BRAIN OEDEMA 282 0.0300
762 INJECTION SITE URTICARIA 473 0.0300
763 EYE PAIN 1071 0.0300
764 PROCEDURAL PAIN 562 0.0299
765 ORAL DISCOMFORT 309 0.0298
766 EPISTAXIS 1663 0.0297
767 HEMIPARESIS 409 0.0297
768 DIPLOPIA 560 0.0297
769 HYPERTHYROIDISM 292 0.0296
770 HEPATITIS C 320 0.0295
771 BLOOD BILIRUBIN INCREASED 634 0.0295
772 CORONARY ARTERY DISEASE 791 0.0295
773 ERYTHEMA 4421 0.0295
774 HYPOACUSIS 827 0.0294
775 URINARY INCONTINENCE 663 0.0294
776 INJECTION SITE REACTION 1510 0.0294
777 PULMONARY ARTERIAL HYPERTENSION 341 0.0293
778 ABASIA 722 0.0292
779 INJECTION SITE PAIN 5673 0.0292
780 GASTROINTESTINAL HAEMORRHAGE 2048 0.0291
781 DEPRESSION 5197 0.0290
782 INTRAOCULAR PRESSURE INCREASED 293 0.0289
783 PANCREATITIS ACUTE 470 0.0288
784 CONSTIPATION 4150 0.0288
785 HAEMORRHAGE 2105 0.0287
786 LIVER DISORDER 882 0.0287
787 UPPER GASTROINTESTINAL HAEMORRHAGE 384 0.0286
788 ADVERSE REACTION 277 0.0286
789 BLOOD ALKALINE PHOSPHATASE INCREASED 583 0.0285
790 ACUTE MYOCARDIAL INFARCTION 680 0.0284
791 FAECES DISCOLOURED 473 0.0284
792 VISION BLURRED 2748 0.0284
793 SYNCOPE 2123 0.0283
794 CARDIAC FAILURE 1630 0.0283
795 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 937 0.0283
796 HYPERSOMNIA 589 0.0282
797 HOT FLUSH 1412 0.0282
798 ABDOMINAL PAIN LOWER 549 0.0282
799 METABOLIC ACIDOSIS 620 0.0281
800 ANXIETY 6000 0.0280
801 LIP SWELLING 690 0.0279
802 RASH PAPULAR 485 0.0277
803 OCULAR HYPERAEMIA 836 0.0276
804 DRY MOUTH 1580 0.0275
805 FLATULENCE 1108 0.0275
806 CHOKING 375 0.0275
807 ROAD TRAFFIC ACCIDENT 853 0.0273
808 MUSCLE SPASMS 3682 0.0273
809 HOSPITALISATION 2546 0.0272
810 INJECTION SITE ERYTHEMA 2464 0.0272
811 HYPERHIDROSIS 2626 0.0271
812 DEAFNESS 506 0.0270
813 PRESYNCOPE 476 0.0270
814 HEAD INJURY 620 0.0270
815 VISUAL IMPAIRMENT 2200 0.0269
816 FULL BLOOD COUNT DECREASED 343 0.0269
817 HYPONATRAEMIA 1123 0.0268
818 INJECTION SITE HAEMORRHAGE 1443 0.0268
819 NEOPLASM PROGRESSION 614 0.0268
820 PREGNANCY 462 0.0268
821 MUSCLE TIGHTNESS 328 0.0267
822 INCORRECT DOSE ADMINISTERED 3219 0.0267
823 DELIRIUM 649 0.0266
824 DIZZINESS 9787 0.0266
825 RETCHING 404 0.0265
826 LETHARGY 1162 0.0265
827 INJURY 1537 0.0265
828 SKIN FISSURES 260 0.0264
829 TRANSIENT ISCHAEMIC ATTACK 715 0.0263
830 FEELING JITTERY 406 0.0263
831 PRODUCT DOSE OMISSION ISSUE 2195 0.0263
832 ACTIVITIES OF DAILY LIVING IMPAIRED 521 0.0263
833 PALPITATIONS 2245 0.0262
834 JAUNDICE 582 0.0262
835 SHOCK 431 0.0262
836 HAEMORRHAGE INTRACRANIAL 324 0.0261
837 PARALYSIS 284 0.0259
838 NERVOUSNESS 1105 0.0259
839 CARDIAC DISORDER 1825 0.0257
840 FEELING ABNORMAL 4724 0.0257
841 COMA 915 0.0255
842 CHOLESTASIS 351 0.0255
843 SKIN REACTION 262 0.0255
844 INJECTION SITE WARMTH 427 0.0255
845 TREMOR 3219 0.0254
846 PRURITUS GENERALISED 551 0.0254
847 INJECTION SITE HAEMATOMA 341 0.0253
848 CHROMATURIA 444 0.0253
849 VENTRICULAR TACHYCARDIA 314 0.0252
850 UNEVALUABLE EVENT 1466 0.0252
851 BLOOD GLUCOSE ABNORMAL 342 0.0251
852 PERITONITIS 408 0.0251
853 SWOLLEN TONGUE 613 0.0250
854 PRESCRIBED UNDERDOSE 325 0.0250
855 URINARY RETENTION 611 0.0249
856 INJECTION SITE SWELLING 1286 0.0248
857 COLON CANCER 276 0.0248
858 THIRST 292 0.0248
859 BLOOD TRIGLYCERIDES INCREASED 350 0.0247
860 ARRHYTHMIA 904 0.0247
861 CENTRAL NERVOUS SYSTEM LESION 287 0.0246
862 ADVERSE EVENT 1649 0.0246
863 MALIGNANT NEOPLASM PROGRESSION 1651 0.0245
864 RESTLESS LEGS SYNDROME 340 0.0244
865 INTERNATIONAL NORMALISED RATIO INCREASED 638 0.0243
866 PRESCRIBED OVERDOSE 333 0.0243
867 VERTIGO 1106 0.0241
868 TINNITUS 822 0.0240
869 SPEECH DISORDER 951 0.0240
870 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 389 0.0239
871 BALANCE DISORDER 1540 0.0237
872 TOXIC EPIDERMAL NECROLYSIS 255 0.0237
873 DEPRESSED MOOD 893 0.0236
874 RASH GENERALISED 613 0.0236
875 DIALYSIS 264 0.0234
876 TREATMENT NONCOMPLIANCE 825 0.0233
877 NO THERAPEUTIC RESPONSE 285 0.0233
878 MELAENA 404 0.0233
879 FACE OEDEMA 300 0.0232
880 MEMORY IMPAIRMENT 2300 0.0232
881 CARDIAC ARREST 1476 0.0231
882 SOMNOLENCE 3329 0.0226
883 HAEMATEMESIS 450 0.0226
884 PRODUCT DOSE OMISSION 1500 0.0224
885 BLOOD GLUCOSE INCREASED 3298 0.0224
886 ORTHOSTATIC HYPOTENSION 293 0.0223
887 LOSS OF CONSCIOUSNESS 2157 0.0223
888 TOXICITY TO VARIOUS AGENTS 2525 0.0222
889 THERAPEUTIC RESPONSE UNEXPECTED 774 0.0221
890 DEVICE MALFUNCTION 896 0.0221
891 APHASIA 516 0.0221
892 LUNG NEOPLASM MALIGNANT 723 0.0221
893 NERVOUS SYSTEM DISORDER 572 0.0220
894 METASTASES TO LIVER 260 0.0216
895 NEOPLASM MALIGNANT 1005 0.0215
896 AGEUSIA 397 0.0215
897 THERAPY CESSATION 735 0.0213
898 BONE LOSS 252 0.0212
899 AMNESIA 1079 0.0212
900 TOOTH LOSS 346 0.0210
901 VISUAL ACUITY REDUCED 622 0.0209
902 FLUSHING 1690 0.0207
903 DISORIENTATION 660 0.0205
904 PANIC ATTACK 568 0.0204
905 COLD SWEAT 276 0.0204
906 UNRESPONSIVE TO STIMULI 395 0.0204
907 MENTAL DISORDER 637 0.0203
908 SENSORY DISTURBANCE 263 0.0202
909 MYOCARDIAL INFARCTION 3026 0.0201
910 DYSARTHRIA 581 0.0199
911 MUSCLE TWITCHING 350 0.0197
912 GAMMA-GLUTAMYLTRANSFERASE INCREASED 357 0.0196
913 ANAPHYLACTIC SHOCK 339 0.0196
914 CRYING 589 0.0196
915 PELVIC PAIN 269 0.0193
916 SEIZURE 1384 0.0193
917 DEMENTIA 348 0.0188
918 CEREBRAL HAEMORRHAGE 519 0.0187
919 MOOD SWINGS 485 0.0186
920 DYSGEUSIA 1006 0.0185
921 EMOTIONAL DISTRESS 1460 0.0185
922 CEREBROVASCULAR ACCIDENT 2479 0.0184
923 SKIN EXFOLIATION 1042 0.0184
924 FEAR 426 0.0184
925 DRUG DOSE OMISSION 3034 0.0183
926 WRONG TECHNIQUE IN DRUG USAGE PROCESS 661 0.0182
927 PSYCHOTIC DISORDER 410 0.0181
928 FOETAL EXPOSURE DURING PREGNANCY 1051 0.0180
929 ANGIOEDEMA 578 0.0179
930 EMOTIONAL DISORDER 441 0.0179
931 HYPOGLYCAEMIA 671 0.0178
932 PAIN OF SKIN 365 0.0178
933 COGNITIVE DISORDER 596 0.0176
934 CARDIO-RESPIRATORY ARREST 586 0.0174
935 ABORTION SPONTANEOUS 542 0.0173
936 CARDIOVASCULAR DISORDER 387 0.0173
937 BLOOD CREATINE PHOSPHOKINASE INCREASED 411 0.0172
938 DEVICE ISSUE 879 0.0168
939 INTENTIONAL PRODUCT MISUSE 1028 0.0164
940 HALLUCINATION 832 0.0162
941 ACNE 989 0.0162
942 DRY SKIN 1391 0.0161
943 GLYCOSYLATED HAEMOGLOBIN INCREASED 275 0.0161
944 HEPATIC FUNCTION ABNORMAL 411 0.0160
945 UNDERDOSE 860 0.0160
946 LACTIC ACIDOSIS 339 0.0159
947 MEDICATION ERROR 658 0.0159
948 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1129 0.0158
949 INJECTION SITE MASS 387 0.0158
950 EYE IRRITATION 545 0.0158
951 AGITATION 922 0.0157
952 IRRITABILITY 755 0.0157
953 BLOOD GLUCOSE DECREASED 603 0.0156
954 MOOD ALTERED 321 0.0156
955 RESTLESSNESS 435 0.0155
956 CEREBRAL INFARCTION 295 0.0155
957 STEVENS-JOHNSON SYNDROME 278 0.0155
958 RHABDOMYOLYSIS 485 0.0154
959 RESPIRATORY ARREST 365 0.0152
960 DEATH 8948 0.0151
961 MENTAL IMPAIRMENT 278 0.0150
962 BRADYCARDIA 593 0.0147
963 DISTURBANCE IN ATTENTION 596 0.0145
964 ANGER 396 0.0143
965 DIABETIC KETOACIDOSIS 252 0.0139
966 EPILEPSY 275 0.0134
967 CONVULSION 766 0.0134
968 SUICIDAL IDEATION 926 0.0133
969 DYSKINESIA 410 0.0132
970 DEPRESSED LEVEL OF CONSCIOUSNESS 391 0.0131
971 MULTIPLE SCLEROSIS 460 0.0126
972 MULTIPLE SCLEROSIS RELAPSE 709 0.0125
973 ABNORMAL BEHAVIOUR 386 0.0113
974 NIGHTMARE 300 0.0110
975 DRUG ADMINISTRATION ERROR 328 0.0107
976 PROSTATE CANCER 668 0.0105
977 ELECTROCARDIOGRAM QT PROLONGED 261 0.0102
978 ACCIDENTAL OVERDOSE 256 0.0100
979 PRODUCT STORAGE ERROR 312 0.0099
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1228 0.0099
981 PRODUCT QUALITY ISSUE 1068 0.0092
982 WITHDRAWAL SYNDROME 275 0.0092
983 AGGRESSION 363 0.0089
984 NO ADVERSE EVENT 908 0.0089
985 VAGINAL HAEMORRHAGE 310 0.0088
986 SKIN IRRITATION 313 0.0086
987 DRUG EXPOSURE DURING PREGNANCY 287 0.0084
988 BREAST CANCER 664 0.0080
989 ACCIDENTAL EXPOSURE TO PRODUCT 353 0.0080
990 SUICIDE ATTEMPT 352 0.0077
991 OVERDOSE 1160 0.0077
992 DRUG DEPENDENCE 964 0.0069
993 SKIN BURNING SENSATION 365 0.0065
994 COMPLETED SUICIDE 291 0.0042
995 DRUG WITHDRAWAL SYNDROME 269 0.0034